AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

LABCORP HOLDINGS INC. Director's Dealing 2021

Mar 31, 2021

30237_dirs_2021-03-30_5b2fd379-536b-4a2d-866c-4dc7ba56b4d6.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LABORATORY CORP OF AMERICA HOLDINGS (LH)
CIK: 0000920148
Period of Report: 2021-03-27

Reporting Person: Caveney Brian J (EVP, President of Diagnostics)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-03-27	Common Stock	A	2413	—	Acquired	9080.1697	Direct
2021-03-27	Common Stock	F	1079	$251.58	Disposed	8001.1697	Direct

Footnotes

F1: Shares acquired on March 27, 2021, pursuant to a performance award granted on February 12, 2018, relating to performance during the three-year period ended December 31, 2020.

F2: Stock withholding to satisfy tax withholding obligations.